DN O'Neal

516 total citations
17 papers, 436 citations indexed

About

DN O'Neal is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, DN O'Neal has authored 17 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in DN O'Neal's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). DN O'Neal is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). DN O'Neal collaborates with scholars based in Australia and United States. DN O'Neal's co-authors include James D. Best, B. Murphy, Fen Lee Hew, F. P. Alford, F P Alford, G.M. Ward, Michael Christopher, Sheila F. O’Brien, V. Burke and Gerald F. Watts and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Diabetologia.

In The Last Decade

DN O'Neal

16 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DN O'Neal Australia 10 291 160 151 92 48 17 436
Gerald Klose Germany 13 218 0.7× 222 1.4× 130 0.9× 65 0.7× 32 0.7× 43 547
M Emoto Japan 5 214 0.7× 101 0.6× 85 0.6× 121 1.3× 48 1.0× 5 465
Sidika E. Kasim United States 8 192 0.7× 136 0.8× 62 0.4× 87 0.9× 60 1.3× 12 419
H Morii Japan 5 282 1.0× 150 0.9× 160 1.1× 122 1.3× 130 2.7× 6 633
G Panzram Germany 7 410 1.4× 107 0.7× 136 0.9× 70 0.8× 35 0.7× 28 597
Onofre Vegazo Spain 15 139 0.5× 215 1.3× 198 1.3× 74 0.8× 67 1.4× 21 578
I.J.A.M. Jonkers Netherlands 13 210 0.7× 223 1.4× 110 0.7× 78 0.8× 14 0.3× 18 541
Hardik Vasnawala India 8 168 0.6× 140 0.9× 96 0.6× 33 0.4× 37 0.8× 12 408
Martin M.-T. Fuh Taiwan 16 423 1.5× 156 1.0× 236 1.6× 122 1.3× 24 0.5× 28 707
Nakayasu Wake Japan 4 565 1.9× 100 0.6× 103 0.7× 89 1.0× 80 1.7× 5 822

Countries citing papers authored by DN O'Neal

Since Specialization
Citations

This map shows the geographic impact of DN O'Neal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DN O'Neal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DN O'Neal more than expected).

Fields of papers citing papers by DN O'Neal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DN O'Neal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DN O'Neal. The network helps show where DN O'Neal may publish in the future.

Co-authorship network of co-authors of DN O'Neal

This figure shows the co-authorship network connecting the top 25 collaborators of DN O'Neal. A scholar is included among the top collaborators of DN O'Neal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DN O'Neal. DN O'Neal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Vogrin, Sara, Barbora Paldus, Dale Morrison, et al.. (2020). Postprandial glucose control using the Medtronic Advanced Hybrid Closed Loop System: faster-acting insulin aspart vs insulin aspart. Diabetologia. 63. 1 indexed citations
2.
Zaharieva, Dessi P., Bhaskar Krishnamurthy, Barbora Paldus, et al.. (2020). ASSESSMENT OF GLYCAEMIA BY FINGERSTICK BLOOD GLUCOSE MONITORING MAY UNDERESTIMATE THE REQUIREMENT FOR INSULIN TO ADDRESS ELEVATED NOCTURNAL GLUCOSE LEVELS IN WOMEN WITH GDM. Diabetes Technology & Therapeutics. 22. 1 indexed citations
3.
Bansal, Akash, et al.. (2014). FIRST EVALUATION OF AN ORTHOGONALLY REDUNDANT GLUCOSE SENSOR SYSTEM IN PEOPLE WITH TYPE 1 DIABETES. Diabetes Technology & Therapeutics. 16. 2 indexed citations
4.
Best, James D. & DN O'Neal. (2012). Diabetes and vascular disease. Diabetes. 22(9). 74–87.
5.
O'Neal, DN, Leonard S. Piers, David Iser, et al.. (2008). Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles. Atherosclerosis. 201(2). 368–377. 27 indexed citations
6.
Mori, Trevor A., V. Burke, Ian B. Puddey, et al.. (2000). Eicosapentaenoic acid and docosahexaenoic acid have differential effects on serum lipids and lipoproteins, LDL-particle size, glucose & insulin, in dyslipidaemic men. Atherosclerosis. 151(1). 110–111. 4 indexed citations
7.
8.
O'Neal, DN, et al.. (1998). Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. Atherosclerosis. 136(1). 1–8. 31 indexed citations
9.
10.
O'Neal, DN, et al.. (1997). High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis. Australian and New Zealand Journal of Medicine. 27(3). 285–293. 3 indexed citations
11.
O'Neal, DN, et al.. (1997). The role of abdominal adiposity and insulin resistance in dyslipidemia of chronic renal failure. American Journal of Kidney Diseases. 29(1). 54–65. 25 indexed citations
12.
O’Brien, Sheila F., Gerald F. Watts, David Playford, et al.. (1997). Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes. Diabetic Medicine. 14(11). 974–978. 64 indexed citations
13.
Best, James D., Geoffrey C. Nicholson, DN O'Neal, et al.. (1996). Atorvastatin and simvastatin reduce elevated cholesterol in non-insulin dependent diabetes. Deakin Research Online (Deakin University). 9(2). 74–80. 32 indexed citations
14.
O'Neal, DN, et al.. (1996). Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. American Journal of Kidney Diseases. 27(1). 84–91. 58 indexed citations
15.
O'Neal, DN, et al.. (1996). Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.. The Journal of Clinical Endocrinology & Metabolism. 81(7). 2448–2454. 44 indexed citations
16.
Best, James D., et al.. (1994). Atorvastatin and simvastatin reduce elevated LDL-cholesterol in type 2 diabetes. Atherosclerosis. 109(1-2). 312–312. 2 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald Klose Breakdown of academic impact, for papers by M Emoto Breakdown of academic impact, for papers by Sidika E. Kasim Breakdown of academic impact, for papers by H Morii Breakdown of academic impact, for papers by G Panzram Breakdown of academic impact, for papers by Onofre Vegazo Breakdown of academic impact, for papers by I.J.A.M. Jonkers Breakdown of academic impact, for papers by Hardik Vasnawala Breakdown of academic impact, for papers by Martin M.-T. Fuh Breakdown of academic impact, for papers by Nakayasu Wake
Rankless by CCL
2026